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Open access under the ElATP-activated P2Y receptors play an important role in renal sodium excretion. The aim of this study was
to evaluate the modulation of ATPase-driven sodium reabsorption in the proximal tubule by ATP or aden-
osine (Ado). LLC-PK1 cells, a model of porcine proximal tubule cells, were used. ATP (10–6 M) or Ado (10–
6 M) speciﬁcally stimulated Na+-ATPase activity without any changes in (Na+ + K+)-ATPase activity. Our
results show that the Ado effect is mediated by its conversion to ATP. Furthermore, it was observed that
the effect of ATP was mimicked by UTP, ATPcS and 2-thio-UTP, an agonist of P2Y2 and P2Y4 receptors. In
addition, ATP-stimulated Na+-ATPase activity involves protein kinase C (PKC). Our results indicate that
ATP-induced stimulation of proximal tubule Na+-ATPase activity is mediated by a PKC-dependent P2Y2
and/or P2Y4 pathway. These ﬁndings provide new perspectives on the role of the effect of P2Y-mediated
extracellular ATP on renal sodium handling.
 2013 Elsevier Inc. Open access under the Elsevier OA license.Introduction
Renal tubular cells secrete 2ATP, which promotes autocrine and
paracrine activity, modulating renal sodium excretion through spe-
ciﬁc P2 receptors: ionotropic P2X and metabotropic P2Y [1–4]. On
the other hand, extracellular ATP can be hydrolyzed by sequential
reactions involving ecto-ATPases and 50-nucleotidase forming aden-rlos Chagas Filho, Universid-
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sevier OA license.osine (Ado) [5]. Similar to ATP, Ado is also able to modulate renal
function through speciﬁc P1 receptors. P1 receptors are members
of the G protein-coupled receptor superfamily (GPCR) and it is fur-
ther subclassiﬁed into A1, A2A, A2B, and A3 receptors [6]. Therefore,
the ﬁnal effect of ATP depends on coordinated mechanisms that in-
volve different receptors and ecto enzymes.
The crucial roles of Ado and ATP in renal sodium excretion dur-
ing physiologic and pathophysiologic events have been reported
previously [7–9]. However, depending on the receptor type in-
volved, ATP or Ado could have contradictory effects on renal so-
dium excretion [6,9]. Infusion of P2Y2 and P2Y4 receptor agonists
in P2Y2–/– knockout mice indicate that these receptors have oppo-
site effects on blood pressure and renal sodium excretion [10]. In
addition, it has been shown that P2Y2 decreases NKCC2 transport
in the thick ascending limb and conductance in the renal epithelial
sodium channel (ENaC) [11,12]. In addition, it has been proposed
that P2X receptors have a role in renal sodium excretion [13].
These receptors were observed to modulate ENaC in distal seg-
ments [14]. Similarly, several studies have shown that Ado recep-
tors have an important role in renal sodium excretion through
modulation of speciﬁc sodium transporters located along the neph-
ron [6].
It is well known that proximal tubule cells are responsible for
reabsorption of 70% of the total sodium ﬁltered in the glomerulus.
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could lead to variations in renal sodium excretion even with com-
pensatory reabsorption of sodium in distal segments of the neph-
ron [15]. This idea is supported by the observation that there is
strict correlation between renal sodium excretion and proximal tu-
bule sodium reabsorption in some pathologic conditions such as
primary hypertension [16]. Furthermore, it has been shown that
proximal tubule cells express P1, P2Y, and P2X receptors [1], and
these receptors modulate sodium transporters in the proximal tu-
bule such as NHE [17] and bicarbonate cotransporters [18]. How-
ever, the activity of these cotransporters depends on the gradient
previously created by sodium pumps.
Transcellular proximal tubule sodium reabsorption is mainly
driven by 2 sodium pumps: ouabain-sensitive (Na+ + K+)-ATPase
activity and furosemide-sensitive Na+-ATPase, called the second
sodium pump [19,20]. In a previous study, it was shown that 10–
3 M ATP inhibits (Na+ + K+)-ATPase [21]. Na+-ATPase was recently
cloned in enterocytes and its role in renal sodium excretion has
been proposed [22]. Our group showed that this enzyme is a target
for receptor-mediated nucleoside activity in the basolateral mem-
brane of proximal tubule cells [7,23]. However, modulation of
proximal tubule Na+-ATPase activity by P2 receptor-mediated
ATP has not yet been studied.
The aim of the present work was to investigate the modulation
of proximal tubule (Na+ + K+)-ATPase and Na+-ATPase activities by
luminal ATP in cultured LLC-PK1 cells, a well-known model of por-
cine proximal tubule cells. It was observed that P2Y-mediated ATP
stimulated Na+-ATPase activity through the activation of protein
kinase C (PKC). These results provide new perspectives on our
understanding of the role of ATP on renal sodium excretion.Materials and methods
Materials
ATP, ouabain, furosemide, HEPES, Tris, Ado, hypoxanthine, ade-
nine, 50-iodotubercidin, pyridoxal phosphate-6-azo(benzene-2,4-
disulfonic acid) (PPADS), UTP, UDP, ATPcS, AMP, and ADP were
purchased from Sigma Chemical Co. (St. Louis, MO). 8-Cyclopen-
tyl-1,3-dipropylxanthine (DPCPX), 3,7-dimethyl-1-propargylxan-
thine (DMPX), MRS1523 were purchased from Research
Biochemicals International (Natick, MA). 2-Thio-UTP and
MRS2693 were purchased from Tocris Bioscience. Rabbit poly-
clonal antibodies against P2Y2 and P2Y4 receptors were purchased
from Santa Cruz Biotechnology Inc., Santa Cruz, CA (Cat. # sc-
20124), and Alomone Labs, Jerusalem, Israel (Cat. #APR-006),
respectively. Polyclonal b-actin antibodies were purchased from
Cell Signaling Technology, Danvers, MA (Cat. #4967). [3H]Ado la-
beled in the 2-position of the adenine moiety (22 Ci/mmol) was
purchased from Amersham Biosciences (UK). Calphostin C was
purchased from Calbiochem (USA). [32P]Pi was obtained from the
Institute of Energetic and Nuclear Research (São Paulo, SP, Brazil).
All other reagents were of the highest purity available. All solutions
were prepared with deionized water. [c-32P]ATP was prepared as
previously described [13].Cell culture
The porcine proximal tubule cell line LLC-PK1 (American Type
Culture Collection, Rockville, MD) was maintained in low-glucose
Dulbecco’s modiﬁed Eagle’s medium (DMEM) complemented with
10% fetal bovine serum and 1% penicillin/streptomycin (37 C and
5% CO2). One-day post-conﬂuence cells were used in all experi-
ments, usually 3 days after seeding. Cells were kept overnight in
serum-free medium before the experiments.Analysis of the metabolism of Ado in LLC-PK1 cells by thin-layer
chromatography
Analysis of the metabolism of [3H]Ado in LLC-PK1 cells was car-
ried out as previously reported by Assaife-Lopes et al. [23] with
some modiﬁcations. Brieﬂy, conﬂuent cultures of LLC-PK1 cells
grown in 24-well plates were incubated with serum-free culture
medium containing 10–7 M [3H]Ado at 37 C for 30 min. Each cul-
ture supernatant was then collected for analysis by thin-layer
chromatography (TLC) and 20% trichloroacetic acid (TCA) was
added to the cell monolayers. The cells were harvested from the
plates and centrifuged for 15 min at 15,000 rpm in an Eppendorf
centrifuge at 4 C. Aliquots (60 ll) of the supernatant from each
cell homogenate as well as culture supernatants were spotted on
the TLC plate (silica gel 60 F254, 16  4 cm, 0.25-mm layer thick-
ness; Merck). The mobile phase consisted of methanol, ethyl ace-
tate, butanol, ammonium hydroxide (3:4:7:4, by vol.). An aliquot
(30 ll) of a mix containing 5 mM of each purine standard (Ado,
inosine, hypoxanthine, adenine nucleotides, and adenine) was also
spotted over each sample. After running for 15 cm, the organic
phase of the TLC was evaporated to dryness at room temperature.
The areas corresponding to metabolites derived from [3H]Ado were
visualized by reﬂection of ultraviolet light by co-migration with
the respective purine standards, scraped from the plates, and
transferred to a scintillation vial containing 0.4% diphenyloxazole
and toluene, Triton X-100, water (8:4:1, by vol.). The radioactivity
contained in each area was quantiﬁed by liquid scintillation count-
ing (Packard Tri-Carb 2100 TR, Downers Grove, IL).Cell homogenate
Conﬂuent cultures of LLC-PK1 cells grown in 6-well plates were
washed with phosphate-buffered saline (PBS) and pre-incubated
with 2 ml of serum-free culture medium (starved) overnight. The
cells were incubated with different drugs as indicated in the ﬁg-
ures. After incubation, the cell monolayers were washed with
PBS and harvested from the plates with 2 ml of PBS. After centrifu-
gation (1000 rpm), cell pellets were resuspended in homogenizing
buffer (0.1% deoxycholic acid, 1 mM EDTA, 20 mM HEPES–Tris (pH
7.0), 250 mM sucrose) and incubated for 30 min at 4 C. The pro-
tein concentration of the cell homogenates was determined by
the Folin phenol method [24] using bovine serum albumin as a
standard.ATPase activity assays
ATPase activity was measured according to the method de-
scribed by Grubmeyer and Penefsky [25]. The composition of the
assay medium (0.1 ml) was 10 mM MgCl2, 30 mM KCl, 20 mM
HEPES–Tris (pH 7.0), 120 mM NaCl, and 5 mM ATP-Na+ (speciﬁc
activity of approximately 104 Bq/nmol ATP). The ATPase activity
of the cell homogenates (the protein concentration in the assay
was 0.2–0.3 mg/ml) was determined by incubating for 20 min at
37 C. The reaction was stopped by the addition of HCl-activated
charcoal (0.1 N). An aliquot of the supernatant was obtained after
centrifugation of the HCl-activated charcoal suspension for 5 min
at 2000 rpm in a clinical centrifuge. [32P]Pi was measured by liquid
scintillation counting (Packard Tri-Carb model A2100TR, Downers
Grove, IL). The (Na+ + K+)-ATPase activity was determined from
the difference between [32P]Pi released in the absence and in the
presence of 1 mM ouabain. The Na+-ATPase activity was deter-
mined from the difference between [32P]Pi released in the absence
and in the presence of 2 mM furosemide (an Na+-ATPase speciﬁc
inhibitor), both in the presence of 1 mM ouabain (an (Na+ + K+)-
ATPase speciﬁc inhibitor) [19,20].
138 M. Wengert et al. / Archives of Biochemistry and Biophysics 535 (2013) 136–142Protein kinase A and C activities
Protein kinase A (PKA) and PKC activities in the cell homoge-
nates were determined as the difference in the transfer of 32Pi from
[c-32P]ATP into histone in the absence and in the presence of PKA
or PKC selective inhibitors, as previously described [7,23]. The
composition of the reaction medium (0.1 ml) was 4 mM MgCl2,
20 mM HEPES–Tris (pH 7.0), 1.5 mg/ml histone, and 0.7 mg/ml
protein. The reaction was started by the addition of [c-32P]ATP
(magnesium salt, 7 lCi/lmol), at a ﬁnal concentration of 10 lM.
After 10 min, the reaction was stopped by the addition of 20%
TCA and the samples were immediately placed on ice. The samples
were ﬁltered using Millipore ﬁlters (0.45 lm) and washed with
ice-cold solution containing 20% TCA and 2 mM phosphate buffer
(pH 7.0). The radioactivity was measured by liquid scintillation
counting (Packard Tri-Carb 2100 TR). PKA activity was considered
to be the difference between the level of 32Pi-phosphorylated pro-
tein in the absence and in the presence of 10–8 M PKAi (PKA inhib-
itor) [32]. PKC activity was considered to be the difference between
the level of 32Pi-phosphorylated protein in the absence and in the
presence of 10–8 M calphostin C (a PKC inhibitor) [26,27].
Immunoblotting
Immunoblotting was carried out to investigate the expression
of P2Y2 and P2Y4 receptors in LLC-PK1 cells. Fifty micrograms of
cell homogenate were loaded onto 9% SDS–PAGE gels and trans-
ferred to polyvinyl diﬂuoride membranes [28]. The membranes
were blocked with TBS 0.05% Tween 20 (TBST) plus 5% non-fat
dry milk for 1 h at room temperature. After 3 washes with ice-cold
0.05% TBST, membranes were incubated for 1 h with rabbit poly-
clonal antibodies raised against human P2Y2 or rat P2Y4 receptors,
diluted 1:300 in 0.05% TBST plus 5% non-fat dry milk. This proce-
dure was followed by 3 consecutive washes with ice-cold 0.05%
TBST.
Thereafter, membranes were incubated with anti-rabbit IgG
horseradish peroxidase-conjugated antibody diluted 1:40,000 in
0.05% TBST plus 5% non-fat dry milk and then washed 3 more times
with 0.05% TBST. The blots were developed using ECL-plus reagent
according to the manufacturer’s instructions.
Statistical analysis of the data
The data were analyzed by 2-way analysis of variance, consider-
ing the treatments as factors. The signiﬁcance of the differences
was veriﬁed by the Bonferroni t-test.Fig. 1. ATP-induced effects on sodium-dependent ATPase activity in LLC-PK1 cells.
(A) ATP (10–6 M) and Ado (10–6 M) stimulated Na+-ATPase activity but did not affect
(Na+ + K+)-ATPase activity. Black bars represent the mean values for each enzyme
activity in the presence of Ado; white bars represent the mean values for each
enzyme activity in the presence of ATP. (B) Ado-induced stimulation of Na+-ATPase
activity was not mediated by P1 receptor subtypes: DPCX, DMPX, and MRS1523 are
A1, A2, and A3 receptor-selective antagonists, respectively. ATPase activity was
measured as described in the Materials and methods section. The results are
expressed as mean ± SE. ⁄Statistically signiﬁcant compared with control (P < 0.05,
n = 8).Results
ATP stimulates Na+-ATPase activity in LLC-PK1 cells
It is well known that proximal tubule cells secrete ATP to the
luminal side [3,4]. The effect of ATP could be correlated to its direct
interaction with speciﬁc P2 receptors or mediated by metabolites
such as Ado through speciﬁc P1 receptors. In the ﬁrst experimental
group, we studied the possible role of extracellular ATP or Ado on
Na+-dependent ATPase activities (Na+-ATPase and (Na+ + K+)-ATP-
ase). LLC-PK1 cells were pre-incubated with serum-free culture
medium (starved) overnight. Cells were washed out and 10–6 M
ATP or 10–6 M Ado was added to the medium for a further
30 min at 37 C. Incubation with ATP or Ado increased the activity
of Na+-ATPase but did not change the activity of (Na+ + K+)-ATPase
(Fig. 1A).
In the next step, we decided to investigate if Ado modulates
Na+-ATPase activity through interaction with speciﬁc P1 receptors.LLC-PK1 cells were incubated with Ado in the presence of classic P1
receptor-selective antagonists. Our results show that the stimula-
tory effect on Na+-ATPase induced by 10–6 M Ado was not affected
by 10–7 M DPCPX, 10–6 M DMPX, or 10–9 M MRS1523 (A1, A2 or A3
receptor-selective antagonists, respectively) (Fig. 1B). The isolated
P1 receptor-selective antagonists tested here did not affect the
activity of Na+-ATPase (data not shown). These data show that
the effect on Na+-ATPase induced by Ado is not mediated by P1
receptors.
Based on the results, we can hypothesize that Ado is being con-
verted to ATP rather than the effect of ATP being mediated by its
conversion to Ado. To test this hypothesis, LLC-PK1 cells were incu-
bated with [3H]Ado and the levels of 3H-labeled adenine nucleo-
tides (AMP, ADP, ATP) were determined by TLC. The level of 3H-
labeled adenine nucleotides was signiﬁcantly increased in the
extracellular medium (Fig. 2A). In addition, 3H-labeled hypoxan-
thine, inosine, and adenine were also increased after the addition
of [3H]Ado to the culture medium.We tested the effect of hypoxan-
thine and adenine on the activity of Na+-ATPase (Fig. 2B). Neither
of these compounds was able to change the enzyme activity, indi-
cating that they do not mediate the stimulatory effect of Ado.
It is possible that sequential phosphorylation of Ado leading to
the formation of ATP is involved in the stimulatory effect of Ado.
Phosphorylation of Ado to AMP is a prerequisite for the Ado-in-
duced effect as shown by incubation of LLC-PK1 cells with Ado in
the presence of 50-iodotubercidin, a speciﬁc inhibitor of adenosine
kinase. 50-iodotubercidin (10–4 M) completely blocked the stimula-
Fig. 2. Ado-induced stimulation of Na+-ATPase activity involves nucleoside phos-
phorylation to ATP. (A) LLC-PK1 cells were incubated with serum-free culture
medium containing 10–7 M [3H]Ado at 37 C for 30 min. After incubation, the
extracellular culture medium was fractionated by TLC and 3H-labeled purine
derivatives ([3H]adenine, [3H]inosine, [3H]hypoxanthine, and [3H]adenine nucleo-
tides) were quantiﬁed by liquid scintillation, as described in the Materials and
methods section. (B) Hypoxanthine and adenine did not affect Na+-ATPase activity.
(C) Adenosine-induced stimulation of Na+-ATPase activity involved adenosine
kinase activity: iodotubercidin (Ido, 10–4 M), an adenosine kinase inhibitor,
prevented the effect induced by Ado (10–6 M) but did not affect the ATP (10–6 M)-
induced stimulation of Na+-ATPase activity. The ATPase activity was measured as
described in the Materials and methods section. The results are expressed as
mean ± SE. ⁄Statistically signiﬁcant compared with control (P < 0.05, n = 8).
Fig. 3. The P2 receptor antagonist PPADS blocked the stimulatory effects induced
by ATP, ATPcS, and Ado on Na+-ATPase activity. (A) The ﬁrst bar shows the enzyme
activity in the absence of either Ado or non-hydrolysable ATP (ATPcS) or ATP;
PPADS (5  10–5 M), a P2 receptor-selective antagonist, prevented the stimulatory
effects on Na+-ATPase activity induced by Ado (10–6 M), ATPcS (10–6 M), and ATP
(10–6 M). (B) PPADS blocks the stimulatory effect of conditioned medium on Na+-
ATPase activity: conﬂuent LLC-PK1 cells were incubated in 10–6 M Ado for 30 min;
the culture medium (conditioned medium) was then transferred to a different
monolayer of LLC-PK1 cells and incubated for 30 min in the absence or in the
presence of 5  10–5 M PPADS. The ATPase activity was measured as described in
the Materials and methods section. The results are expressed as mean ± SE.
⁄Statistically signiﬁcant compared with control (P < 0.05, n = 7).
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fect the stimulatory effect induced by ATP (Fig. 2C).
The P2 receptor-mediated stimulatory effect of ATP on Na+-ATPase
activity
To investigate the involvement of P2 receptors in the stimula-
tory effects induced by ATP on Na+-ATPase activity, LLC-PK1 cells
were incubated simultaneously with 10–6 M ATP, 10–6 M Ado, or
10–6 M non-hydrolysable ATP (ATPcS) in the presence or absence
of 5  10–5 M PPADS, a nonspeciﬁc P2 receptor antagonist. Our re-
sults show that PPADS blocked the stimulatory effects induced byATP, Ado, or ATPcS on Na+-ATPase activity (Fig. 3A), indicating a P2
receptor-mediated response for ATP. In addition, ATPcS mimicked
the effect of ATP conﬁrming that hydrolysis of ATP is not necessary
for its ﬁnal effect on the enzyme activity. The possibility that basal
ATP could be modulating Na+-ATPase activity in LLC-PK1 cells can
be ruled out because PPADS did not have this effect in the absence
of added ATP.
We showed that part of Ado has already been converted to ade-
nine nucleotides (AMP, ADP, ATP) after 30 min of incubation. Fur-
thermore, in the time course experiments we observed that Ado
metabolism in luminal side of LLC-PK1 is maximal after 10 min
of incubation (data not shown). Then, in another experimental ap-
proach cells were incubated with 10–6 M Ado for 30 min. The cul-
ture medium (conditioned medium) was then collected and added
to another culture of LLC-PK1 cells and Na+-ATPase activity was
measured (Fig. 3B). The conditioned medium increased the enzyme
activity by 55%, similar to the effect observed in the presence of
added ATP. In addition, the stimulatory effect induced by the con-
ditioned medium was abolished by 5  10–5 M PPADS.
Our data demonstrate that the stimulatory effect induced by
Ado depends on its conversion to ATP which is involved in the
modulation of proximal tubule Na+-ATPase activity.
Fig. 4. Involvement of P2Y2/P2Y4 receptor in the stimulatory effect of ATP on Na+-
ATPase activity. (A) ATP (10–6 M) and UTP (10–6 M), a classic agonist for P2Y
receptors, stimulated Na+-ATPase activity, but UDP (10–6 M), a selective agonist of
P2Y6 receptor, and ADP (10–6 M), which is able to bind to the P2Y1 receptor, did not
affect the enzyme activity. (B) The activation of P2Y6 receptor was not able to
+
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receptor-mediated PKC activation
The existence of P2Y1, P2Y2, P2Y4, and P2Y6 in proximal tubules
has been demonstrated previously [29,30]. Involvement of the P2Y
receptor subtype on the stimulatory effect of ATP on Na+-ATPase
activity was demonstrated using UTP, a classic agonist for P2Y
receptors (Fig. 4A). UTP (10–6 M) stimulated Na+-ATPase activity
in a similar manner to ATP. Interestingly, 106 M ADP, which is
able to bind to the P2Y1 receptor, did not change the Na+-ATPase
activity. The possible role of the P2Y6 receptor was investigated
using UDP (Fig. 4A) and MRS2693 (Fig. 4B), a selective agonists
of this receptor [31]. Neither compound changed the enzyme activ-
ity, suggesting that P2Y6 is not involved in the stimulatory effect of
ATP.
We also tested the effect of 2-thio-UTP, an agonist for P2Y2 (at
nanomolar concentration) and P2Y4 (at micromolar concentration)
receptors [32]. It was observed that this agonist increased Na+-
ATPase activity at both lower (0.05 lM) and higher (0.5 lM) con-
centrations (Fig. 4C). The maximal stimulatory effect was similar
to that found for 10–6 M ATP or 10–6 M ATPcS. So far, our results
show that the metabotropic P2Y2 and/or P2Y4 subfamily is likely
the P2 receptor subtype involved in the modulation of Na+-ATPase
activity by ATP. In addition, the expression of P2Y2 and P2Y4 recep-
tors in LLC-PK1 cells was evaluated by immunoblotting using poly-
clonal-speciﬁc antibodies and revealed expression of both
receptors (Fig. 5). The smooth second band observed in P2Y2 blot-
ting probably represents the degradation of the protein. The immu-
noblotting using only secondary antibody was carried out and the
second band does not appear (data not shown).
It has been shown that Na+-ATPase activity can be modulated
by PKA and PKC [7,23,26,27]. In addition, modulation of the PKA
and PKC signaling pathways by P2Y2 and P2Y4 receptors has been
reported previously [2]. For those reasons, conﬂuent LLC-PK1 cells
were incubated with 10–6 M ATP or 10–6 M Ado for 30 min and cell
homogenates were used to measure the activity of PKA and PKC.
Our results show that ATP or Ado did not modulate PKA activity
(Fig. 6A). In sharp contrast, both ATP and Ado stimulated PKC activ-
ity, which was completely blocked by 5  10–5 M PPADS. This stim-
ulation was equivalent to that promoted by 10–12 M phorbol
myristate acetate (PMA), a classic activator of PKCs (Fig. 6B). The
possible relationship between the stimulation of PKC and stimu-
lated Na+-ATPase activity was demonstrated by using 10–8 M cal-
phostin C, a speciﬁc inhibitor of PKC. The stimulatory effects of
ATP on Na+-ATPase activity were completely blocked by calphostin
C (Fig. 6C).stimulate Na -ATPase activity: LLC-PK1 was incubated with MRS2693 (from 20 to
1000 nM), an agonist of P2Y6, but the Na+-ATPase activity was not affected. (C) 2-
Thio-UTP, an agonist of P2Y2/P2Y4 receptors, stimulated Na+-ATPase activity: low
and high concentrations of 2-thio-UTP stimulated Na+-ATPase activity in a similar
manner. ATPase activity was measured as described in the Materials and methods
section. The results are expressed as mean ± SE. ⁄Statistically signiﬁcant compared
with control (P < 0.05, n = 12).
Fig. 5. Immunodetection of P2Y2 and P2Y4 receptors. LLC-PK1 proteins were
separated by 9% PAGE–SDS. P2Y2 and P2Y4 receptors were detected by immuno-
blotting using speciﬁc polyclonal antibodies (in duplicate), as described in the
Materials and methods section. b-actin was used as a loading control. Lane 1 and 2
represent different preparations of the LLC-PK1 cells.Discussion
The role of extracellular ATP on cellular functions through spe-
ciﬁc P2 receptors has been a topic of interest [1,4]. ATP is secreted
by renal epithelial cells, through apical and basolateral mem-
branes, but the full effect on the function of these cells is not
known. In the present work, we showed that extracellular ATP acti-
vates P2Y2 and/or P2Y4 receptors in the plasma membrane of LLC-
PK1 cells, stimulating Na+-ATPase activity through a PKC signalling
pathway. These results provide new perspectives on understand-
ing the role of ATP on the sodium transporters located in proximal
tubule cells.
We used LLC-PK1 cells, which could be a limitation in determin-
ing the ﬁnal effect of P2Y2 and/or P2Y4 receptor activation on prox-
imal tubule sodium reabsorption and, consequently, renal sodium
excretion. However, LLC-PK1 cells have been widely used as a
model of proximal tubule cells and the results obtained in these
cells are usually reproduced in proximal tubule cells [7,23,33,34].
Fig. 6. Stimulatory effects induced by ATP and Ado on Na+-ATPase activity involved
PKC activation. (A) Neither ATP nor Ado modulated PKA activity. (B) ATP and Ado
stimulated PKC activity in a PPDAS-sensitive manner and these stimulatory effects
were similar to those of PMA, an activator of PKC. (C) Stimulatory effects induced by
ATP and Ado on Na+-ATPase activity were blocked by calphostin C (Calph C), a
speciﬁc inhibitor of PKC. The ATPase and protein kinase activities were measured as
described in the Materials and methods section. The results are expressed as
mean ± SE. ⁄Statistically signiﬁcant compared with control (P < 0.05, n = 6).
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lar and extracellular (ecto-) enzymes, such as nucleoside triphos-
phate diphosphohydrolases (NTPDases), nucleotide
pyrophosphatase/phosphodiesterase (NPPases) and 50-nucleotid-
ase [5,34]. A functional role of the extracellular unidirectional
metabolism of adenine nucleotides into Ado in the kidney has been
suggested previously [35]. In a previous study, our group showed
that Ado added to the basolateral membrane modulates the activ-
ity of Na+-ATPase activity via P1 receptors: A1 and A2. Activation of
A1 was reported to lead to a decrease in enzyme activity and inter-
action with A2 increases it [7,23]. In addition, this biphasic effectdepends on the inhibition or activation of the cAMP/PKA pathway.
In contrast, in the present work, ATP was found to be a mediator of
the luminal Ado-induced stimulatory effect on Na+-ATPase activity.
These data indicate that there is a differential metabolism of Ado at
the luminal and basolateral membranes of proximal tubule cells.
Ouabain-insensitive Na+-ATPase was recently cloned in entero-
cytes [22]. However, even before it was cloned, the evidence indi-
cated that this enzyme is involved in sodium transport in different
cell types including proximal tubule cells [26,27]. Malnic et al. [36]
observed that furosemide inhibits Na+ reabsorption in the proximal
tubule. It has been proposed that Na+-ATPase is involved in ﬁne
tuning Na+ reabsorption in the proximal tubule [23]; this is sup-
ported by the observation that change in Na+-ATPase leads to sig-
niﬁcant changes in sodium reabsorption in proximal tubule cells in
spontaneously hypertensive rats [37]. In addition, it has been
shown that this enzyme is a target to several hormones and autac-
oids involved in the modulation of renal sodium excretion
[7,23,26,27,38,39].
In the present work, we observed that apical ATP 10–6 M af-
fected Na+-ATPase activity speciﬁcally but did not change the
activity of (Na+ + K+)-ATPase in LLC-PK1 cells incubated for
30 min. Jin and Hopfer et al. [21] demonstrated that apical ATP
10–3 M inhibits (Na+ + K+)-ATPase activity in WKPT1292 C1.8 cells
(Wistar Kyoto rat kidney proximal tubule cells), measured by
short-circuit current, in a rapid (1 min) and transient way. These
apparently contradictory results can be explained by differences
in the ATP concentration, time of incubation, or even due to the
methodology used to measure the (Na+ + K+)-ATPase activity. In
addition, these apparent contradictory effects might reveal an
important balance between the activity of 2 sodium pumps: at a
lower concentration, ATP could stimulate sodium reabsorption
through Na+-ATPase, whereas at a higher level, as a result of cell
leakage, ATP could inhibit the massive sodium reabsorption
through (Na+ + K+)-ATPase.
The role of ATP in proximal tubule sodium reabsorption may be
related to the concentration of ATP, which binds to different P2X
and P2Y receptors expressed in this segment [40]. The following
observations indicate that the effect of ATP on the activity of
Na+-ATPase is mediated by P2Y2 and/or P2Y4: (1) UTP, ATPcS,
and 2-thio-UTP mimicked the stimulatory effect of ATP on Na+-
ATPase activity; (2) PKC mediates the ATP effect. It is well known
that P2Y receptors can trigger a cellular response through activa-
tion of PKC [2].
The proximal tubule is the nephron segment with the highest
level of secretion of ATP. Veckaria et al. [3] measured the concen-
tration of ATP in the lumen of proximal tubules from rat kidney
and found that it ranged from 100 to 300 nmol/l. These values
could reach micromolar concentrations depending on the physio-
logic or pathophysiologic conditions. Because P2Y receptor sub-
types have high afﬁnity for ATP, its luminal concentration could
be high enough to activate these receptors [2,10]. Our results sug-
gest that ATP secretion at the luminal membrane could be an
important mechanism in modulating proximal tubule sodium
reabsorption through a P2Y2 and/or P2Y4 receptor.
The role of P2Y receptors in proximal tubule sodium reabsorp-
tion has been postulated [1]. The expression of P2Y6 was shown in
Xenopus oocytes, in basolateral membrane, and the stimulation of
this receptor increased NaCl secretion [41]. Activation of the apical
proximal tubule P2Y1 receptor has been associated with a decrease
in bicarbonate that involves the NHE3 cotransporter [18]. The re-
sults for luminal Ap4A perfusion, which binds to P2Y1 and P2Y4,
show a decrease in fractional proximal tubular reabsorption [42].
Our data show that ATP, through PKC-mediated P2Y2 and/or P2Y4
receptor, increases Na+-ATPase activity in LLC-PK1 cells. Although
P2Y2 and P2Y4 receptors are able to increase PKC activity, studies
by Rieg et al. [43] on P2Y2 receptor knockout mice infused with
142 M. Wengert et al. / Archives of Biochemistry and Biophysics 535 (2013) 136–142the P2Y2,4 agonist, INS45973, indicate that both receptors could
have opposite effects on blood pressure and renal sodium excre-
tion. They observed that P2Y4 increased blood pressure and de-
creased renal sodium excretion. On the other hand, the P2Y2
activation decreased blood pressure and increased renal sodium
excretion. Thus, our results indicate that the effect of ATP on
Na+-ATPase activity could be involved in antinatriuresis induced
by P2Y4 receptor or a mechanism to counterbalance the natriuretic
effect of P2Y2 receptor, promoting ﬁne control of sodium reabsorp-
tion in proximal tubule cells.
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